BBA
BLB&B Advisors Portfolio holdings
AUM
$2.14B
This Quarter Return
-4.29%
1 Year Return
+14.81%
3 Year Return
+57.03%
5 Year Return
+90.76%
10 Year Return
+188.63%
AUM
$1.49B
AUM Growth
+$1.49B
(-3.3%)
Cap. Flow
+$27.8M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
42.49%
Holding
262
New
7
Increased
80
Reduced
129
Closed
12
Top Buys
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$6.01M |
| 2 |
Schwab US Mid-Cap ETF
SCHM
|
$5.59M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
$5.15M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$4.77M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$3.93M |
Top Sells
| 1 |
Schlumberger
SLB
|
$4.45M |
| 2 |
Vanguard Ultra-Short Bond ETF
VUSB
|
$1.84M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$1.73M |
| 4 |
3M
MMM
|
$651K |
| 5 |
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
|
$628K |
Sector Composition
| 1 | Technology | 11.63% |
| 2 | Healthcare | 7.52% |
| 3 | Financials | 6.65% |
| 4 | Consumer Staples | 4.12% |
| 5 | Industrials | 3.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
AGNC Investment
AGNC
$10.2B
| – | – |
-10,250
| Closed | -$154K |
|
252
AstraZeneca
AZN
$248B
| – | – |
-5,775
| Closed | -$336K |
|
253
Biogen
BIIB
$19.4B
| – | – |
-843
| Closed | -$202K |
|
254
Darden Restaurants
DRI
$24.1B
| – | – |
-1,650
| Closed | -$249K |
|
255
Quaker Houghton
KWR
$2.52B
| – | – |
-1,000
| Closed | -$231K |
|
256
Alliant Energy
LNT
$16.7B
| – | – |
-3,529
| Closed | -$217K |
|
257
Thermo Fisher Scientific
TMO
$186B
| – | – |
-337
| Closed | -$225K |
|
258
Unilever
UL
$155B
| – | – |
-9,009
| Closed | -$485K |
|
259
UnitedHealth
UNH
$281B
| – | – |
-440
| Closed | -$221K |
|
260
Waters Corp
WAT
$18B
| – | – |
-600
| Closed | -$224K |
|
|
RDS.A
261
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-9,221
| Closed | -$400K |
|